
Functional Services CRO
Execution you can trust. Oversight you can verify.
Our Services
Clinical Research Operations supports the planning, execution, and oversight of clinical trials.
-
Clinical trial project and program management
-
Clinical Research Associates (CRAs) and site monitoring
-
Trial start-up and site activation
-
Clinical operations and vendor oversight
-
Regulatory documentation and Trial Master File (TMF) management
-
Clinical data management and study closeout
-
Clinical quality and risk management
Independent GxP Auditing provides compliance oversight across regulated clinical, laboratory, and manufacturing environments.
-
Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Manufacturing Practice (GMP) audits
-
Clinical investigator site and vendor audits
-
Contract Research and Manufacturing Organization (CRO/CMO) audits
-
Quality management system and SOP assessments
-
Corrective and Preventive Action (CAPA) oversight
-
FDA inspection preparation and mock inspections
Compliance & Quality
The key advantage is independence
RxRS CRO keeps the people running the study separate from the people checking it. Clinical staff focus on execution, while GxP auditors assess compliance and inspection readiness without a conflict of interest. Clients get a built-in second opinion without hiring and managing a separate auditor.
-
Operational flexibility: Specialists are deployed as program milestones require, not kept on payroll year-round.
-
Cost control: Staffing scales with actual project demand, which avoids the fixed cost of maintaining specialized teams in-house.
-
Regulatory confidence: Oversight spans GCP, GLP, and GMP, so one partner covers the standards that matter across a program from nonclinical work through clinical trials.
-
Risk mitigation: Quality and compliance gaps are found and resolved early, before they threaten an FDA submission or inspection.
-
Accountability: Defined responsibilities, documented deliverables, and measurable performance expectations give the client clear grounds to evaluate the partnership.
